Explore

Trendline Trendline
Novocure Reports Strong Q1 2026 Financial Results with Growth in Optune Gio Therapy

Novocure Reports Strong Q1 2026 Financial Results with Growth in Optune Gio Therapy

Novocure Reports Strong Q1 2026 Financial Results with Growth in Optune Gio Therapy
Trendline Trendline
CareDx Reports 39% Revenue Growth in Q1 2026, Raises Annual Guidance

CareDx Reports 39% Revenue Growth in Q1 2026, Raises Annual Guidance

CareDx Reports 39% Revenue Growth in Q1 2026, Raises Annual Guidance
Trendline Trendline
NutriBand Reports $2.04M Revenue and $8.23M Net Loss for Fiscal Year 2026

NutriBand Reports $2.04M Revenue and $8.23M Net Loss for Fiscal Year 2026

NutriBand Reports $2.04M Revenue and $8.23M Net Loss for Fiscal Year 2026
Trendline Trendline
Incyte to Present at May 2026 Investor Conferences, Highlighting Biopharmaceutical Innovations

Incyte to Present at May 2026 Investor Conferences, Highlighting Biopharmaceutical Innovations

Incyte to Present at May 2026 Investor Conferences, Highlighting Biopharmaceutical Innovations
Trendline Trendline
Avantor Reports Stable First Quarter 2026 Financial Results Amid Market Challenges

Avantor Reports Stable First Quarter 2026 Financial Results Amid Market Challenges

Avantor Reports Stable First Quarter 2026 Financial Results Amid Market Challenges
Trendline Trendline
Avantor Reports Q1 2026 Financial Results, Reaffirms Full-Year Guidance

Avantor Reports Q1 2026 Financial Results, Reaffirms Full-Year Guidance

Avantor Reports Q1 2026 Financial Results, Reaffirms Full-Year Guidance
Trendline Trendline
Meta Reports Strong Financial Performance in Q1 2026 Amidst Strategic Developments

Meta Reports Strong Financial Performance in Q1 2026 Amidst Strategic Developments

Meta Reports Strong Financial Performance in Q1 2026 Amidst Strategic Developments
Trendline Trendline
ADC Therapeutics to Announce Q1 2026 Financial Results in Upcoming Conference Call

ADC Therapeutics to Announce Q1 2026 Financial Results in Upcoming Conference Call

ADC Therapeutics to Announce Q1 2026 Financial Results in Upcoming Conference Call
Trendline Trendline
ADC Therapeutics Announces First Quarter 2026 Financial Results Call

ADC Therapeutics Announces First Quarter 2026 Financial Results Call

ADC Therapeutics Announces First Quarter 2026 Financial Results Call
Trendline Trendline
Revolution Medicines Challenges Erasca Over Pancreatic Cancer Drug Patent Infringement

Revolution Medicines Challenges Erasca Over Pancreatic Cancer Drug Patent Infringement

Revolution Medicines Challenges Erasca Over Pancreatic Cancer Drug Patent Infringement
Trendline Trendline
Coca-Cola Reports Strong First Quarter 2026 Results with Revenue and EPS Growth

Coca-Cola Reports Strong First Quarter 2026 Results with Revenue and EPS Growth

Coca-Cola Reports Strong First Quarter 2026 Results with Revenue and EPS Growth
Trendline Trendline
Veradermics Initiates Public Offering to Expand Dermatology Innovations

Veradermics Initiates Public Offering to Expand Dermatology Innovations

Veradermics Initiates Public Offering to Expand Dermatology Innovations